- Home
- CSBR vs LFT Comparison
CSBR vs LFT Comparison
Compare CSBR & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- LFT
- Stock Information
- Founded
- CSBR 1985
- LFT 2012
- Country
- CSBR United States
- LFT United States
- Employees
- CSBR N/A
- LFT N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- LFT Real Estate Investment Trusts
- Sector
- CSBR Health Care
- LFT Real Estate
- Exchange
- CSBR Nasdaq
- LFT Nasdaq
- Market Cap
- CSBR 90.2M
- LFT 92.1M
- IPO Year
- CSBR 1986
- LFT N/A
- Fundamental
- Price
- CSBR $6.48
- LFT $1.78
- Analyst Decision
- CSBR Strong Buy
- LFT Hold
- Analyst Count
- CSBR 1
- LFT 1
- Target Price
- CSBR $12.00
- LFT N/A
- AVG Volume (30 Days)
- CSBR 15.1K
- LFT 158.8K
- Earning Date
- CSBR 09-15-2025
- LFT 11-11-2025
- Dividend Yield
- CSBR N/A
- LFT 13.33%
- EPS Growth
- CSBR N/A
- LFT N/A
- EPS
- CSBR 0.21
- LFT 0.18
- Revenue
- CSBR $56,878,000.00
- LFT $25,803,999.00
- Revenue This Year
- CSBR $7.31
- LFT $124.75
- Revenue Next Year
- CSBR $12.01
- LFT N/A
- P/E Ratio
- CSBR $30.18
- LFT $10.00
- Revenue Growth
- CSBR 10.11
- LFT N/A
- 52 Week Low
- CSBR $3.75
- LFT $1.75
- 52 Week High
- CSBR $11.99
- LFT $2.84
- Technical
- Relative Strength Index (RSI)
- CSBR 47.59
- LFT 32.89
- Support Level
- CSBR $6.29
- LFT $1.75
- Resistance Level
- CSBR $6.79
- LFT $1.88
- Average True Range (ATR)
- CSBR 0.25
- LFT 0.06
- MACD
- CSBR 0.03
- LFT -0.01
- Stochastic Oscillator
- CSBR 33.83
- LFT 18.97
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About LFT Lument Finance Trust Inc.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.